Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
post-transplantation cyclophosphamide
DRUG
2 trials
Sponsors
Peking University People's Hospital
Conditions
Hematological Malignancy
Hematopoietic Stem Cell Transplantation
Phase 4
Post-transplantation Cyclophosphamide for Haploidentical Transplant From Maternal or Collateral Donors
Completed
NCT02412423
Peking University People's Hospital
Hematopoietic Stem Cell Transplantation
Start: 2015-03-31
End: 2017-03-31
Updated: 2020-09-17
Unknown Phase
The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation
NCT05629260
Peking University People's Hospital
Hematological Malignancy
Start: 2022-12-01
End: 2025-12-31
Target: 300
Updated: 2023-09-11
Related Papers
TGF-β1-triggered maladaptive bone marrow endothelium impedes hematopoietic recovery.
2025-10-07
1 citations